Phibro Animal Health (PAHC) Capital Expenditures Growth (1y) (2014 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | -27.73% |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | -19.86% |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | -42.11% |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 43.58% |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.58% |
| Mar 31, 2026 | 97.73% |
| Dec 31, 2025 | 41.87% |
| Sep 30, 2025 | 44.07% |
| Jun 30, 2025 | 0.54% |
| Mar 31, 2025 | -20.40% |
| Dec 31, 2024 | -28.62% |
| Sep 30, 2024 | 28.18% |
| Jun 30, 2024 | 20.03% |
| Mar 31, 2024 | 23.05% |
| Dec 31, 2023 | 11.61% |
| Sep 30, 2023 | -67.74% |
| Jun 30, 2023 | -8.40% |
| Mar 31, 2023 | -21.04% |
| Dec 31, 2022 | 27.69% |
| Sep 30, 2022 | 211.13% |
| Jun 30, 2022 | 67.61% |
| Mar 31, 2022 | 33.75% |
| Dec 31, 2021 | 5.08% |
| Sep 30, 2021 | 0.39% |